halimi-board-bw-photo-01 copy.JPG

HOJI ALIMI

FOUNDER, CHAIRMAN AND CEO

  • 20 years of experience in the global healthcare industry

  • Chairman, CEO Ruthigen, Inc.

  • IPO experience, including raising $170M in capital

  • FDA and CE approvals of multiple drugs and devices

 
gregf-bw-3 copy[1].JPG

GREG FRENCH

DIRECTOR, COLLIDION, INC.

  • Co-owner of G&C Enterprises LLC, a real estate and investment company, which he founded in 1999.

  • Held various engineering and senior management positions at several medical device companies, including Advanced Cardiovascular Systems, Peripheral Systems Group and Arterial Vascular Engineering. Previously served on the Board of Directors of Oculus Innovative Sciences, Inc. and Ruthigen, Inc.


Screen Shot 2019-10-28 at 3.44.47 PM.png

Jeffrey Castillo

DIRECTOR, COLLIDION, INC.

  • President, Microsurgical Technologies

  • V.P. Commercial Operations, Americas, Abbott Medical Optics (AMO)

  • Johnson & Johnson, Inc., 21 years in a variety of roles including Sales & Marketing Manager for the Infection Control Division, International Business Director for Latin America, Regional Director for Ethicon, Director of US Sales & Marketing for Advanced Sterilization Products

 
ronc-bw copy.JPG

RON CARLI

DIRECTOR, SPECTRUM ANTIMICROBIALS

  • Former President & CEO, America AgCredit for 32 years

  • Forged the creation of Agricultural Credit Associations (ACA) by integrating short, intermediate and long-term credit authorities under one umbrella, and negotiated multiple mergers.

  • Master of Science in Agricultural Science, Cal Poly, Sa Luis Obispo


headshotbw.jpg

Ettore CArino

DIRECTOR, COLLDION, INC.

  • Former Senior Vice President, Johnson & Johnson Medical Devices. Commercial Leader, Americas, Advanced Sterilization Products (ASP).

  • Over 30 years of Medical Device Industry experience in areas of Sales, Marketing, Product Development, Business Development, and Finance.

  • Successfully launched and commercially scaled up several innovative medical devices in the areas of General Surgery, Orthopedics, Women’s Health, Urology, and Infection Prevention.

  • Led the completion of several Public Mergers, Licensing, Co-Development, and Distribution deals at Johnson & Johnson.